Skip to main content
. 2019 Nov 25;10(12):884. doi: 10.1038/s41419-019-2124-x

Fig. 2. Silencing miR-155-5p inhibited allergic inflammation in the AD model.

Fig. 2

a Flow chart of antagomir-155-5p administration to AD murine model. b Representative images of mouse ears on day 6 after challenge with FITC. c, g Histopathological changes examined with H&E staining (n = 5; magnification: ×100; scale bar: 200 μm). The number of inflammatory cells was quantified with the Mantra Quantitative Pathology Workstation. d Expression of miR-155-5p was detected with PCR. e, f Ear thicknesses and ear weights were measured on day 7. hk Th2 cytokine production was measured in ear homogenates with ELISAs (mean ± SD; n = 7; #P < 0.05, ###P < 0.001 versus control, *P < 0.05, **P < 0.01, ***P < 0.001 versus model).